Periorbital edema and phototoxic rash associated with dasatinib: A case report
Dasatinib is an effective agent in the treatment of bcr-abl positive acute lymphoblastic leukemia and chronic myeloid leukemia cases. Various skin reactions may occur when tyrosine kinase inhibitors are used. The severity of side effects increases in phototoxic reactions with sunlight. In this case,...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-03-01
|
| Series: | SAGE Open Medical Case Reports |
| Online Access: | https://doi.org/10.1177/2050313X251330969 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850206018997321728 |
|---|---|
| author | Bera Omer Ugurlu Umit Yavuz Malkan |
| author_facet | Bera Omer Ugurlu Umit Yavuz Malkan |
| author_sort | Bera Omer Ugurlu |
| collection | DOAJ |
| description | Dasatinib is an effective agent in the treatment of bcr-abl positive acute lymphoblastic leukemia and chronic myeloid leukemia cases. Various skin reactions may occur when tyrosine kinase inhibitors are used. The severity of side effects increases in phototoxic reactions with sunlight. In this case, a phototoxic rash that developed in a 78-year-old bcr-abl positive acute lymphoblastic leukemia patient is presented. This case supports that phototoxic reactions may occur with dasatinib and emphasizes that clinicians should be alert for this side effect. |
| format | Article |
| id | doaj-art-1b7c304f708f4d49a6f3e520c2da51c0 |
| institution | OA Journals |
| issn | 2050-313X |
| language | English |
| publishDate | 2025-03-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | SAGE Open Medical Case Reports |
| spelling | doaj-art-1b7c304f708f4d49a6f3e520c2da51c02025-08-20T02:10:57ZengSAGE PublishingSAGE Open Medical Case Reports2050-313X2025-03-011310.1177/2050313X251330969Periorbital edema and phototoxic rash associated with dasatinib: A case reportBera Omer Ugurlu0Umit Yavuz Malkan1Division of Hematology, Department of Internal Medicine, Hacettepe University Medical Faculty, Ankara, TurkeyDivision of Hematology, Department of Internal Medicine, Hacettepe University Medical Faculty, Ankara, TurkeyDasatinib is an effective agent in the treatment of bcr-abl positive acute lymphoblastic leukemia and chronic myeloid leukemia cases. Various skin reactions may occur when tyrosine kinase inhibitors are used. The severity of side effects increases in phototoxic reactions with sunlight. In this case, a phototoxic rash that developed in a 78-year-old bcr-abl positive acute lymphoblastic leukemia patient is presented. This case supports that phototoxic reactions may occur with dasatinib and emphasizes that clinicians should be alert for this side effect.https://doi.org/10.1177/2050313X251330969 |
| spellingShingle | Bera Omer Ugurlu Umit Yavuz Malkan Periorbital edema and phototoxic rash associated with dasatinib: A case report SAGE Open Medical Case Reports |
| title | Periorbital edema and phototoxic rash associated with dasatinib: A case report |
| title_full | Periorbital edema and phototoxic rash associated with dasatinib: A case report |
| title_fullStr | Periorbital edema and phototoxic rash associated with dasatinib: A case report |
| title_full_unstemmed | Periorbital edema and phototoxic rash associated with dasatinib: A case report |
| title_short | Periorbital edema and phototoxic rash associated with dasatinib: A case report |
| title_sort | periorbital edema and phototoxic rash associated with dasatinib a case report |
| url | https://doi.org/10.1177/2050313X251330969 |
| work_keys_str_mv | AT beraomerugurlu periorbitaledemaandphototoxicrashassociatedwithdasatinibacasereport AT umityavuzmalkan periorbitaledemaandphototoxicrashassociatedwithdasatinibacasereport |